This is a guest post from law professor Michael Trebilcock and lawyer Dan Poliwoda:     THE TRIPS VACCINE WAIVER CONTROVERSY* By Michael Trebilcock Emeritus University Professor of LawUniversity of Toronto     Dan Poliwoda Lawyer, Dickinson Wright LLP University of Toronto (J.D., 2020)    July 12, 2021 *We acknowledge the invaluable research assistance of Daniel Scarpitti, University of Toronto, Faculty of Law, 2L, in preparing these comments. [read post]

In this episode, you’ll learn about: The prior art, or evidence, of earlier technology that EFF was able to present to courts to prove that the so-called “podcasting patent” was invalid How the landmark Alice v. [read post]

Prelude to Litigation Phenylpropanolamine (PPA) was a widely used direct α-adrenergic agonist used as a medication to control cold symptoms and to suppress appetite for weight loss.[1] In 1972, an over-the-counter (OTC) Advisory Review Panel considered the safety and efficacy of PPA-containing nasal decongestant medications, leading, in 1976, to a recommendation that the agency label these medications as “generally recognized as safe and effective. [read post]